Literature DB >> 18852528

Heterozygous mutation of HESX1 causing hypopituitarism and multiple anatomical malformations without features of septo-optic dysplasia.

G Corneli1, D Vivenza, F Prodam, G Di Dio, A Vottero, A Rapa, S Bellone, S Bernasconi, G Bona.   

Abstract

Isolated GH deficiency or combined pituitary hormone deficiencies have been associated with mutations in transcription factors encoding genes that control organogenesis or cell differentiation. Among these factors, Hesx1 is essential for the development of the optic nerve and regulates some of the earliest stages in pituitary development and is intimately involved in orchestrating the expression of other factors involved in pituitary organogenesis. Mutations in HESX1 are reported in patients with hypopituitarism either with typical septo-optic dysplasia (SOD) or with neuromorphological abnormalities not included in classical SOD. The present report describes clinical features, biochemical parameters, and characterization of a missense mutation (Gln6His) in exon1 of HESX1 in a pre-pubertal child who progressively developed multiple hypopituitarism, firstly GH and, afterwards, TSH and ACTH deficiencies, in a pluri-malformative syndrome characterized by short stature and anatomical malformations not associated with a classical SOD phenotype. This finding further supports the necessity to stay alert in evaluating a gene that plays a minor role in the pathogenesis of sporadic hypopituitarism, such as HESX1 gene even when the phenotype does not fit in with a classical SOD syndrome.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18852528     DOI: 10.1007/BF03346416

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  20 in total

Review 1.  Multistep signaling and transcriptional requirements for pituitary organogenesis in vivo.

Authors:  M G Rosenfeld; P Briata; J Dasen; A S Gleiberman; C Kioussi; C Lin; S M O'Connell; A Ryan; D P Szeto; M Treier
Journal:  Recent Prog Horm Res       Date:  2000

Review 2.  HESX1 and Septo-Optic Dysplasia.

Authors:  Mehul Tulsidas Dattani; Iain Caf Robinson
Journal:  Rev Endocr Metab Disord       Date:  2002-12       Impact factor: 6.514

Review 3.  Molecular basis of combined pituitary hormone deficiencies.

Authors:  Laurie E Cohen; Sally Radovick
Journal:  Endocr Rev       Date:  2002-08       Impact factor: 19.871

4.  Hormonal, pituitary magnetic resonance, LHX4 and HESX1 evaluation in patients with hypopituitarism and ectopic posterior pituitary lobe.

Authors:  Maria Edna Melo; Suemi Marui; Luciani Renata Carvalho; Ivo Jorge Prado Arnhold; Claudia Costa Leite; Berenice Bilharinho Mendonça; Mirta Knoepfelmacher
Journal:  Clin Endocrinol (Oxf)       Date:  2007-01       Impact factor: 3.478

5.  A simple salting out procedure for extracting DNA from human nucleated cells.

Authors:  S A Miller; D D Dykes; H F Polesky
Journal:  Nucleic Acids Res       Date:  1988-02-11       Impact factor: 16.971

6.  The Ames dwarf gene, df, is required early in pituitary ontogeny for the extinction of Rpx transcription and initiation of lineage-specific cell proliferation.

Authors:  P J Gage; M L Brinkmeier; L M Scarlett; L T Knapp; S A Camper; K A Mahon
Journal:  Mol Endocrinol       Date:  1996-12

7.  Heterozygous HESX1 mutations associated with isolated congenital pituitary hypoplasia and septo-optic dysplasia.

Authors:  P Q Thomas; M T Dattani; J M Brickman; D McNay; G Warne; M Zacharin; F Cameron; J Hurst; K Woods; D Dunger; R Stanhope; S Forrest; I C Robinson; R S Beddington
Journal:  Hum Mol Genet       Date:  2001-01-01       Impact factor: 6.150

8.  Alu-element insertion in the homeodomain of HESX1 and aplasia of the anterior pituitary.

Authors:  Marie-Laure Sobrier; Irène Netchine; Claudine Heinrichs; Nathalie Thibaud; Marie-Pierre Vié-Luton; Guy Van Vliet; Serge Amselem
Journal:  Hum Mutat       Date:  2005-05       Impact factor: 4.878

9.  The homeobox gene Hesx1 is required in the anterior neural ectoderm for normal forebrain formation.

Authors:  J P Martinez-Barbera; T A Rodriguez; R S Beddington
Journal:  Dev Biol       Date:  2000-07-15       Impact factor: 3.582

10.  HESX1 mutations are an uncommon cause of septooptic dysplasia and hypopituitarism.

Authors:  David E G McNay; James P Turton; Daniel Kelberman; Kathryn S Woods; Raja Brauner; Anastasios Papadimitriou; Eberhard Keller; Alexandra Keller; Nele Haufs; Heiko Krude; Stephen M Shalet; Mehul T Dattani
Journal:  J Clin Endocrinol Metab       Date:  2006-12-05       Impact factor: 5.958

View more
  5 in total

Review 1.  Combined pituitary hormone deficiency: current and future status.

Authors:  F Castinetti; R Reynaud; M-H Quentien; N Jullien; E Marquant; C Rochette; J-P Herman; A Saveanu; A Barlier; A Enjalbert; T Brue
Journal:  J Endocrinol Invest       Date:  2014-09-09       Impact factor: 4.256

2.  Identification of HESX1 mutations in Kallmann syndrome.

Authors:  Kayce Newbern; Nithya Natrajan; Hyung-Goo Kim; Lynn P Chorich; Lisa M Halvorson; Richard S Cameron; Lawrence C Layman
Journal:  Fertil Steril       Date:  2013-03-01       Impact factor: 7.329

3.  Genetic causes of hypopituitarism.

Authors:  Katherine Parkin; Ritika Kapoor; Ravindra Bhat; Anne Greenough
Journal:  Arch Med Sci       Date:  2019-12-31       Impact factor: 3.318

4.  Homozygous HESX1 and COL1A1 Gene Variants in a Boy with Growth Hormone Deficiency and Early Onset Osteoporosis.

Authors:  Viola Alesi; Maria Lisa Dentici; Silvia Genovese; Sara Loddo; Emanuele Bellacchio; Valeria Orlando; Silvia Di Tommaso; Giorgia Catino; Chiara Calacci; Giusy Calvieri; Daniele Pompili; Graziamaria Ubertini; Bruno Dallapiccola; Rossella Capolino; Antonio Novelli
Journal:  Int J Mol Sci       Date:  2021-01-13       Impact factor: 5.923

Review 5.  Genetic regulation of pituitary gland development in human and mouse.

Authors:  Daniel Kelberman; Karine Rizzoti; Robin Lovell-Badge; Iain C A F Robinson; Mehul T Dattani
Journal:  Endocr Rev       Date:  2009-10-16       Impact factor: 19.871

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.